echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Clinical trials to develop a new crown for the treatment of severe diseases in the pharmaceutical industry have been officially launched in Brazil

    Clinical trials to develop a new crown for the treatment of severe diseases in the pharmaceutical industry have been officially launched in Brazil

    • Last Update: 2021-03-09
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    The clinical trial of pruceline for the treatment of severe neo-crown patients is a multi-center, randomized, double-blind, placebo parallel-controlled study initiated by researchers to explore the effectiveness of psylone in patients with severe neo-coronary disease.
    The clinical trial program recruited 294 male and 294 female patients and included them in the "pruamine plus standard treatment" trial group and the "placebo plus standard treatment" control group, all of whom were hospitalized with new crown patients 18 years of age and older, respectively.
    group, patients were orally taking 300 mg of psyruamine once a day for 14 days.
    control group, patients were given a 300 mg placebo once a day for 14 days.
    end of clinical trials was the effectiveness of the 14-day proclosamine treatment group relative to the control group (assessed by the WHO 8 scale).
    note: There are deletions in the original text
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.